TRULICITY (DULAGLUTIDE subcutaneous injection) Patient Assistance Program
Don’t let the high cost of brand once-weekly GLP-1 receptor agonist disrupt your type 2 diabetes care. We help eligible patients access Trulicity (dulaglutide subcutaneous injection) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Trulicity (dulaglutide) is FDA-approved as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients ≥10 years with type 2 diabetes, and to reduce the risk of major adverse cardiovascular events (MACE — CV death, nonfatal MI, nonfatal stroke) in adults with T2DM with established cardiovascular disease or multiple cardiovascular risk factors. Once-weekly subcutaneous injection — long-acting GLP-1 receptor agonist with cardiovascular outcome benefits (REWIND trial).
- Without assistance, brand Trulicity costs commonly run approximately $930–$1,200 per 30-day supply (4 weekly injections).
- Through AffordMyPrescriptions, qualifying patients can access Trulicity for a flat $69.95 per month.
- Other GLP-1 receptor agonists: semaglutide (Ozempic SC weekly for T2DM, Wegovy SC weekly for weight loss, Rybelsus oral daily), tirzepatide (Mounjaro for T2DM, Zepbound for weight loss — dual GLP-1/GIP agonist with higher A1C and weight reduction), liraglutide (Victoza for T2DM, Saxenda for weight loss — daily injection, generic emerging), exenatide (Byetta twice-daily, Bydureon weekly — older agents, less prescribed now), lixisenatide (Adlyxin). SGLT2 inhibitors (Jardiance, Farxiga — also IRA negotiated for Medicare 2026) offer different mechanism with HF/CKD benefits. Foundational diabetes therapy: metformin (generic, very cheap, first-line per ADA), generic sulfonylureas, generic pioglitazone, DPP-4 inhibitors, basal insulins.
What Is Trulicity Prescription Assistance Program?
The Trulicity Patient Assistance Program is a manufacturer-sponsored initiative that helps eligible patients access Trulicity (used for type 2 diabetes glycemic control and cardiovascular risk reduction) at little or no cost when they meet specific income, insurance, and clinical criteria. The program is free to apply for, but the enrollment process involves detailed applications, endocrinology or primary care coordination, supporting documentation, and ongoing renewal — which can be overwhelming when you are managing type 2 diabetes with cardiovascular risk.
At AffordMyPrescriptions, our Patient Advocates handle the entire Trulicity PAP enrollment for a flat $69.95 per month. We complete the application, coordinate with your prescriber for required medical documentation, follow up with the manufacturer’s program until approval, manage your once-weekly auto-injector refills, and handle annual re-certification — so you never face a gap in your Trulicity GLP-1 receptor agonist therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Trulicity enrollment — from the initial application through ongoing refills and annual re-enrollment — so you never face a gap in your type 2 diabetes treatment.
Pharmacy Price Comparison
- Without assistance, Trulicity costs around a thousand dollars per month at retail pharmacies. Discount cards and pharmacy coupons offer some relief, but they don't come close to what a Patient Assistance Program provides if you qualify. The table below compares typical retail pricing across major pharmacies to what you'd pay with our Trulicity advocacy service:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$1,150/mo | Save substantially |
| CVS Pharmacy | ~$1,200/mo | Save substantially |
| Walmart | ~$960/mo | Save substantially |
| Costco | ~$930/mo | Save substantially |
| Ozempic (alt weekly GLP-1 | ~$1,000/mo | Alt weekly GLP-1 |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Trulicity — independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Trulicity Prescription Program?
The Trulicity Patient Assistance Program is free to apply and provides medication at no cost if approved. But the process involves detailed applications, prescriber coordination, documentation, and ongoing management — applications that are commonly delayed or denied when paperwork is incomplete. Our $69.95 per month covers full advocacy: applications, doctor coordination, documentation, refill management, and re-enrollment — so you focus on your health, not paperwork. Generic metformin remains foundational first-line and very inexpensive — GLP-1 receptor agonists are added for cardiovascular and weight management benefits beyond glucose control.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Trulicity:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
Coupon cards expire and require constant renewal
Still $930–$1,200 per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Trulicity assistance.
- You are a U.S. citizen or legal resident
- You have a valid Trulicity prescription from a licensed U.S. healthcare provider For treatment
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Trulicity:
Trulicity is a once-weekly long-acting GLP-1 receptor agonist for type 2 diabetes — designed with an Fc-fusion protein structure for an extended half-life supporting weekly dosing. Cardiovascular outcome benefit (REWIND trial) demonstrated MACE reduction in T2DM with established CVD or multiple CV risk factors. The auto-injector pen design simplifies once-weekly self-administration.
How Trulicity works:
Type 2 diabetes involves insulin resistance, progressive beta-cell dysfunction, and impaired GLP-1 incretin response. GLP-1 normally stimulates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and promotes satiety.
Dulaglutide is a long-acting GLP-1 receptor agonist — stimulates pancreatic beta cells to secrete insulin in a glucose-dependent manner (so risk of hypoglycemia is low without concurrent insulin or sulfonylureas), suppresses excess glucagon, slows gastric emptying, and reduces appetite. The Fc-fusion design extends half-life to ~5 days enabling once-weekly dosing. Cardiovascular benefits demonstrated in REWIND independent of baseline ASCVD.
Form and use:
Trulicity 0.75 mg, 1.5 mg, 3 mg, or 4.5 mg subcutaneous injection once weekly via single-use auto-injector pen. Starting dose 0.75 mg weekly for glycemic control; titrate to 1.5 mg weekly. May further increase to 3 mg or 4.5 mg for additional A1C lowering. Same day each week; may switch day if needed. Injection in abdomen, thigh, or upper arm. Rotate sites. Refrigerate.
Generic availability:
No generic Trulicity. Other GLP-1 receptor agonists: semaglutide (Ozempic SC weekly for T2DM, Wegovy SC weekly for obesity, Rybelsus oral daily — same active molecule), tirzepatide (Mounjaro for T2DM, Zepbound for obesity — dual GLP-1/GIP agonist with superior A1C and weight reduction), liraglutide (Victoza SC daily for T2DM, Saxenda SC daily for obesity — generic emerging), exenatide (Byetta twice-daily SC, Bydureon weekly SC — older agents), lixisenatide (Adlyxin SC daily — older agent). Other T2DM lines: metformin (generic, foundational first-line per ADA — very cheap), SGLT2 inhibitors (Jardiance, Farxiga — IRA negotiated for Medicare 2026; Invokana; Brenzavvy — cheaper class option), generic sulfonylureas (caution hypoglycemia), generic pioglitazone, DPP-4 inhibitors (Januvia going generic, Tradjenta), basal insulins (glargine biosimilars, Toujeo, degludec/Tresiba), prandial insulins. Combination products: Soliqua (insulin glargine + lixisenatide), Xultophy (insulin degludec + liraglutide). Lifestyle interventions (diet, exercise, weight management, smoking cessation, BP and lipid management) are foundational.
Warnings:
**Boxed warning: thyroid C-cell tumors (medullary thyroid carcinoma observed in rodent studies — contraindicated in personal or family history of MTC or Multiple Endocrine Neoplasia type 2).** Other: pancreatitis (rare but reported — discontinue if suspected), severe hypoglycemia (when combined with insulin or sulfonylureas — reduce those agents), acute kidney injury (especially with dehydration from nausea/vomiting), hypersensitivity reactions, gallbladder disease (cholecystitis, cholelithiasis), diabetic retinopathy complications with rapid A1C reduction (consider in advanced retinopathy), gastroparesis worsening (slowed gastric emptying — caution with severe baseline gastroparesis), nausea, vomiting, diarrhea (very common — typically improve with continued use; titration helps), increased heart rate (modest), pulmonary aspiration risk during anesthesia (consider holding GLP-1 agonist before surgery per evolving anesthesia guidance).
FAQ (Frequently Asked Questions)
How much does Trulicity cost without insurance?
The list price is approximately $987 per month for four prefilled pens (28-day supply), consistent across all dose strengths. Retail prices at pharmacies can range up to ~$1,396 depending on location. With GoodRx coupons, prices range from ~$1,018 (Publix) to ~$1,116 (Costco). SingleCare offers a best price of approximately $825 per month at participating pharmacies. Through AffordMyPrescriptions, qualifying patients receive Trulicity at no medication cost — our $69.95 monthly fee covers advocacy and program management.
What is the difference between Trulicity and Ozempic?
Both are once-weekly GLP-1 receptor agonists for T2DM with cardiovascular benefits. Trulicity is dulaglutide; Ozempic is semaglutide. Both effective. Ozempic typically achieves greater A1C and weight reduction; Trulicity may be slightly better tolerated. Choice often by insurance, prior trials, and patient preference.
What is the difference between Trulicity and Mounjaro?
Trulicity is a single GLP-1 receptor agonist. Mounjaro (tirzepatide) is a dual GLP-1/GIP receptor agonist — substantially greater A1C and weight reduction in head-to-head trials. Mounjaro is generally more potent but with similar safety profile and slightly more GI side effects at high doses. Both once-weekly SC injections. Insurance often determines initial choice.
Why is a GLP-1 receptor agonist added when generic metformin is much cheaper?
Metformin remains foundational first-line per ADA guidelines and very cheap. GLP-1 receptor agonists are added because the class has strong outcomes data beyond glucose lowering — cardiovascular event reduction (REWIND for Trulicity), substantial weight loss, and slowed CKD progression in some trials. Preferred 2nd-line in patients with ASCVD, multiple CV risk factors, or obesity per ADA/EASD.
Does Trulicity cause weight loss?
Yes — modest weight reduction (about 3–5 kg in trials) is common. Less than semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro/Zepbound). Weight loss is desirable for most T2DM patients but is not Trulicity’s primary indication (Wegovy and Zepbound are FDA-approved for chronic weight management).
What are the most common Trulicity side effects?
Yes — modest weight reduction (about 3–5 kg in trials) is common. Less than semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro/Zepbound). Weight loss is desirable for most T2DM patients but is not Trulicity’s primary indication (Wegovy and Zepbound are FDA-approved for chronic weight management).
Can Trulicity be used in pediatric patients?
Yes — approved for pediatric patients ≥10 years with T2DM. Same once-weekly subcutaneous injection.
What happens if my Trulicity Patient Assistance Program application is denied?
We help explore Ozempic copay programs (alternative weekly GLP-1), Mounjaro copay programs (dual GLP-1/GIP — more potent), Victoza (liraglutide generic emerging), Saxenda copay, Rybelsus (oral semaglutide), SGLT2 inhibitor alternatives (Jardiance, Farxiga, Brenzavvy — IRA negotiated for Medicare 2026), generic metformin foundation therapy optimization, foundation aid (ADA, American Heart Association, Patient Access Network, NeedyMeds), Medicare Part D Extra Help, and lifestyle support for weight management and CV risk reduction.
Take Control of Your Medication Costs
Type 2 diabetes and cardiovascular risk reduction should not be skipped over cost. Foundational generic metformin remains very inexpensive — GLP-1 receptor agonists add important CV and weight benefits. Our Trulicity advocacy team is ready to verify your eligibility, complete the manufacturer application on your behalf, and manage your prescription through approval, delivery, and renewal — for a flat $69.95 per month. If we cannot help you access Trulicity through a Patient Assistance Program, you are not charged. Call (833) 556-2729 or check your eligibility online today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.